Drug Discoveries & Therapeutics
Online ISSN : 1881-784X
Print ISSN : 1881-7831
ISSN-L : 1881-7831
Reviews
HDAC6: Physiological function and its selective inhibitors for cancer treatment
Penghui YangLei ZhangYingjie ZhangJian ZhangWenfang Xu
著者情報
ジャーナル フリー

2013 年 7 巻 6 号 p. 233-242

詳細
抄録
Acetylation and deacetylation of histones are important in regulating gene expression and play a key role in modification of gene transcription. Specific HDACs isoforms can be regarded as a target for cancer therapy avoiding side-effects, HDAC6 with a unique physiological function and structure has become a hot issue recently. The unique isoform HDAC6 is involved in tumorigenesis, development and metastasis through tubulin, HSP90, invasin and ubiquitin-protein. Here we review the structure elements, biological function, and recent selective inhibitors of HDAC6, and study the structure-activity and structureselectivity relationship.
著者関連情報
© 2013 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
前の記事 次の記事
feedback
Top